Thermo Fisher Scientific Inc (TMO) Growth Rates Comparisons to Scientific & Technical Instruments Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Thermo Fisher Scientific Inc   (NYSE: TMO)
 

Thermo Fisher Scientific Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TMO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 9.13 % 8.48 % 26.95 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) 1.19 % -5.28 % -1.66 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 8.27 % 8.1 % 18.04 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 2.19 % 2.22 % 5.86 % 2.61 %
Revenue 5 Year Average Growth 6.7 % 8.71 % 11.15 % 13.63 %


TMO's Growth Comparisons in III. Quarter 2026




Comparing 9.13% year on year Revenue growth in the third quarter 2026, Thermo Fisher Scientific Inc outperformed the 8.48% growth in the Scientific & Technical Instruments industry, but Thermo Fisher Scientific Inc 's growth compares unfavorably, to the 26.95% Revenue increase in the Technology sector.

Comparing the company's Revenue to the second quarter results, sales were higher by 1.19% . On the yearly basis, average annual sales growth for Thermo Fisher Scientific Inc is 6.7%, while S & P 500's including only Businesses with the third quarter 2026 earnings, average annual sales growth is 13.63% over the past five years.

TMO Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Life Sciences Solutions
12.6 %
-
Analytical Instruments
-0.12 %
-
Specialty Diagnostics
-0.52 %
-
Specialty Diagnostics IntersubEliminations
-
-
Laboratory Products and Biopharma Services
7.02 %
-
Laboratory Products and Biopharma Services IntersubEliminations
-
-
Total Reportable Segments
6.3 %
-
Total Reportable Life Sciences Solutions
12.6 %
-
Total Reportable Life Sciences Solutions Biosciences
-1.21 %
-
Total Reportable Life Sciences Solutions Genetic sciences
-3.25 %
-
Total Reportable Life Sciences Solutions BioProduction
33.08 %
-
Total Reportable Life Sciences Solutions Other
-
-
Total Reportable Analytical Instruments
-0.12 %
-
Total Reportable Analytical Instruments Chromatography and mass spectrometry
3.23 %
-
Total Reportable Analytical Instruments Chemical analysis
-0.35 %
-
Total Reportable Analytical Instruments Electron microscopy
-3.95 %
-
Total Reportable Specialty Diagnostics
-0.52 %
-
Total Reportable Specialty Diagnostics Clinical diagnostics
3.04 %
-
Total Reportable Specialty Diagnostics ImmunoDiagnostics
5.99 %
-
Total Reportable Specialty Diagnostics Microbiology
5.26 %
-
Total Reportable Specialty Diagnostics Transplant diagnostics
7.08 %
-
Total Reportable Specialty Diagnostics Healthcare market channel
-9.28 %
-
Total Reportable Laboratory Products and Biopharma Services
7.02 %
-
Total Reportable Laboratory Products and Biopharma Services Laboratory products
-2.23 %
-
Total Reportable Laboratory Products and Biopharma Services Research and safety market channel
5.79 %
-
Total Reportable Laboratory Products and Biopharma Services Pharma services
8.34 %
-
Total Reportable Laboratory Products and Biopharma Services Clinical research
9.75 %
-
Elimination of interrevenues
-
-
North America
3.48 %
-
Europe
12.69 %
-
Asia-Pacific
4.18 %
-
Other regions
10.39 %
-
Consumables
8.45 %
-
Instruments
-4.37 %
-
Services
7.85 %
-
Reconciling Items
8.71 %
-
Reconciling Items Life Sciences Solutions
7.75 %
-
Reconciling Items Analytical Instruments
19.51 %
-
Reconciling Items Specialty Diagnostics
0 %
-
Reconciling Items Laboratory Products and Biopharma Services
10.81 %
-
Total
6.18 %
-


Growth Rates of TMO's Income in the third quarter 2026


TMO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 16.59 % 11.68 % 54.64 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) 8.43 % -8.28 % 1.18 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) 12.8 % 16.57 % 34.68 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) 3.95 % 3.64 % 11.15 % 20.86 %
Operating Income 5 Year Avg. Change -0.12 % 6.28 % 18.17 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 6.17 % 13.14 % 81.1 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) -1.15 % -9.38 % 14.55 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 7.82 % 6.11 % 50.18 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 1.43 % 4.4 % 17.21 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 1.06 % 7.07 % -45.6 % -28.64 %

TMO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 6.17 % 9.78 % 81.11 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) -1.15 % -7.94 % 15.84 % 27.07 %
Y / Y Net Income Change (Q3 TTM) 7.82 % 4.63 % 50.08 % 57.33 %
Sequential Net Income Change (Q3 TTM) 1.43 % 3.68 % 17.28 % 18.65 %
Net Income 5 Year Avg. Growth 1.06 % 7.16 % 18.17 % 23.95 %

TMO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 8.64 % 8.89 % 81.1 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) -0.64 % -9.92 % 14.55 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 9.3 % 285.77 % - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 1.99 % 14.56 % - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 2.01 % 0.42 % -45.6 % -28.64 %



TMO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 8.67 % 5.66 % 81.11 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) -0.85 % -8.49 % 15.84 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - 255.85 % - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 1.99 % 10.87 % - 4.93 %
EPS Net 5 Year Avg. Change 2.14 % 7.16 % 18.17 % 23.95 %



Comparing 8.67% year on year EPS growth in the third quarter, Thermo Fisher Scientific Inc outperformed the 5.66% growth in the Scientific & Technical Instruments industry, but Thermo Fisher Scientific Inc 's growth compares unfavorably, to the 81.11% EPS rise in the Technology sector.

the bottom-line fell by -0.85% from the second quarter. Average annual income per share growth for Thermo Fisher Scientific Inc is 2.14%, while S & P 500's average yearly income per share increase is 23.95%, including only Businesses with the third quarter 2026 earnings.

TMO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 15.15 % 14.51 % 16.23 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) 26.15 % -57.97 % -17.8 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) 24.3 % -1.84 % 22.59 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) 3.8 % -12.88 % 3.89 % 15.75 %
Free Cash Flow 5 Year Avg. Change -1.47 % 3.45 % 8.28 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) - - 53.29 % 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - - -5.42 % 152.64 %
Net Cash Flow 5 Year Avg. Change -5.9 % -8.84 % 4.45 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 8.17 % 4.98 % 68.91 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) -2.89 % -19.95 % 10.38 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) 12.21 % 17.93 % 64.65 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) 1.95 % 7.51 % 14.16 % 23.05 %
Capital Expenditures 5 Year Avg. Change 0.68 % 6.59 % 22.99 % 14.2 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.